Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2

Reviews in Medical Virology

Volumn 13, Issue 5, 2003, Pages 331-340

  Kawaguchi, Yasushi ^a,b,c   Kato, Kentaro ^c,d  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GENE PRODUCT; INITIATION FACTOR; INITIATION FACTOR EF 1DELTA; PROTEIN KINASE; UNCLASSIFIED DRUG;

DNA SYNTHESIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; LIFE CYCLE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; VIROGENESIS; VIRUS CAPSID;

ANIMALS; CDC2 PROTEIN KINASE; HERPESVIRIDAE; HUMANS; PHOSPHORYLATION; PROTEIN KINASES; VIRAL PROTEINS;

EID: 0041837470     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.402     Document Type: Review

References (81)

1. Roizman B, Pellett PE. The family Herpesviridae: a brief introduction. In Fields Virology, Knipe DM, Howley PM, Griffin DE, et al. (eds). Lippincott-Williams & Wilkins, Philadelphia, 2001; 2381-2397.
2. Stevens JG. Human herpesviruses: a consideration of the latent state. Microbiol Rev 1989; 53: 318-332.
3. Garcia-Blanco MA, Cullen BR. Molecular basis of latency in pathogenic human viruses. Science 1991; 254: 815-820.
4. Jordan MC, Jordan GW, Stevens JG, et al. Latent herpesviruses of humans. Ann Intern Med 1984; 100: 866-880.
5. Whitley RJ. Herpes simplex viruses. In Fields Virology, Knipe DM, Howley PM, Griffin DE, et al. (eds). Lippincott-Williams & Wilkins, Philadelphia, 2001; 2461-2509.
6. Honess RW, Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 1974; 14: 8-19.
7. Edelman AM, Blumenthal DK, Krebs EG. Protein serine/threonine kinases. Annu Rev Biochem 1987; 56: 567-613.
8. Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science 2002; 298: 1912-1934.
9. McGeoch DJ, Davison AJ. Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res 1986; 14: 1765-1777.
10. Chee MS, Lawrence GL, Barrell BG. Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J Gen Virol 1989; 70: 1151-1160.
11. Smith RF, Smith TF. Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J Virol 1989; 63: 450-455.
12. Chung TD, Wymer JP, Smith CC, et al. Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J Virol 1989; 63: 3389-3398.
13. Conner J, Cooper J, Furlong J, et al. An autophosphorylating but not transphosphorylating activity is associated with the unique N terminus of the herpes simplex virus type 1 ribonucleotide reductase large subunit. J Virol 1992; 66: 7511-7516.
14. Daikoku T, Shibata S, Goshima F, et al. Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2. Virology 1997; 235: 82-93.
15. Kenyon TK, Lynch J, Hay J, et al. Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol 2001; 75: 8854-8858.
16. Park J, Lee D, Seo T, et al. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase. J Gen Virol 2000; 81: 1067-1071.
17. Kato K, Kawaguchi Y, Tanaka M, et al. Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells. J Gen Virol 2001; 82: 1457-1463.
18. Kawaguchi Y, Kato K, Tanaka M, et al. Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J Virol 2003; 77: 2359-2368.
19. Ansari A, Emery VC. The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J Virol 1999; 73: 3284-3291.
20. He Z, He YS, Kim Y, et al. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol 1997; 71: 405-411.
21. Chen MR, Chang SJ, Huang H, et al. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J Virol 2000; 74: 3093-3104.
22. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 1988; 241: 42-52.
23. de Wind N, Domen J, Berns A. Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells. J Virol 1992; 66: 5200-5209.
24. Gershburg E, Pagano JS. Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94. J Virol 2002; 76: 998-1003.
25. Purves FC, Roizman B. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22. Proc Natl Acad Sci USA 1992; 89: 7310-7314.
26. Coulter LJ, Moss HW, Lang J, et al. A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted. J Gen Virol 1993; 74: 387-395.
27. Purves FC, Ogle WO, Roizman B. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc Natl Acad Sci USA 1993; 90: 6701-6705.
28. Cunningham C, Davison AJ, Dolan A, et al. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J Gen Virol 1992; 73: 303-311.
29. Ng TI, Ogle WO, Roizman B. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 1998; 241: 37-48.
30. Ogle WO, Ng TI, Carter KL, et al. The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0. Virology 1997; 235: 406-413.
31. Roizman B, Knipe DM. Herpes simplex viruses and their replication. In Fields Virology, Knipe DM, Howley PM, Griffin DE, et al. (eds). Lippincott-Williams & Wilkins, Philadelphia, 2001; 2399-2459.
32. Advani SJ, Brandimarti R, Weichselbaum RR, et al. The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes. J Virol 2000; 74: 8-15.
33. Long MC, Leong V, Schaffer PA, et al. ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J Virol 1999; 73: 5593-5604.
34. Hagglund R, Munger J, Poon AP, et al. U(S)3 protein kinase of herpes simplex virus 1 blocks caspase 3 activation induced by the products of U(S)1.5 and U(L)13 genes and modulates expression of transduced U(S)1.5 open reading frame in a cell type-specific manner. J Virol 2002; 76: 743-754.
35. Overton HA, McMillan DJ, Klavinskis LS, et al. Herpes simplex virus type 1 gene UL13 encodes a phosphoprotein that is a component of the virion. Virology 1992; 190: 184-192.
36. Morrison EE, Wang YF, Meredith DM. Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J Virol 1998; 72: 7108-7114.
37. Kawaguchi Y, Van Sant C, Roizman B. Eukaryotic elongation factor 1delta is hyperphosphorylated by the protein kinase encoded by the U(L)13 gene of herpes simplex virus 1. J Virol 1998; 72: 1731-1736.
38. Bruni R, Fineschi B, Ogle WO, et al. A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and is recruited to the nucleus after infection. J Virol 1999; 73: 3810-3817.
39. Ng TI, Grose C. Serine protein kinase associated with varicella-zoster virus ORF 47. Virology 1992; 191: 9-18.
40. Stevenson D, Colman KL, Davison AJ. Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J Gen Virol 1994; 75: 317-326.
41. Heineman TC, Cohen JI. The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22. J Virol 1995; 69: 7367-7370.
42. Moffat JF, Zerboni L, Sommer MH, et al. The ORF47 and ORF66 putative protein kinases of varicellazoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci USA 1998; 95: 11969-11974.
43. Soong W, Schultz JC, Patera AC, et al. Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol 2000; 74: 1864-1870.
44. Ng TI, Keenan L, Kinchington PR, et al. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol 1994; 68: 1350-1359.
45. Kenyon TK, Cohen JI, Grose C. Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane. J Virol 2002; 76: 10980-10993.
46. Reddy SM, Cox E, Iofin I, et al. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is post-translationally modified by the VZV ORF47 protein kinase. J Virol 1998; 72: 8083-8088.
47. van Zeijl M, Fairhurst J, Baum EZ, et al. The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 1997; 231: 72-80.
48. Kawaguchi Y, Matsumura T, Roizman B, et al. Cellular elongation factor 1 delta is modified in cells infected with representative alpha-, beta-, or gamma-herpesviruses. J Virol 1999; 73: 4456-4460.
49. Baek MC, Krosky PM, He Z, et al. Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase. Importance of the P + 5 position. J Biol Chem 2002; 277: 29593-29599.
50. Baek MC, Krosky PM, Coen DM. Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase. J Virol 2002; 76: 11943-11952.
51. Littler E, Stuart AD, Chee MS. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 1992; 358: 160-162.
52. Talarico CL, Burnette TC, Miller WH, et al. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob Agents Chemother 1999; 43: 1941-1946.
53. Sullivan V, Talarico CL, Stanat SC, et al. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992; 358: 162-164.
54. Drew WL, Buhles W, Erlich KS. Herpesvirus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). How to use ganciclovir (DHPG) and acyclovir. Infect Dis Clin North Am 1988; 2: 495-509.
55. Prichard MN, Gao N, Jairath S, et al. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol 1999; 73: 5663-5670.
56. Wolf DG, Courcelle CT, Prichard MN, et al. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci USA 2001; 98: 1895-1900.
57. Biron KK, Harvey RJ, Chamberlain SC, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother 2002; 46: 2365-2372.
58. Krosky PM, Baek MC, Coen DM. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol 2003; 77: 905-914.
59. Cannon JS, Hamzeh F, Moore S, et al. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J Virol 1999; 73: 4786-4793.
60. Ng TI, Talarico C, Burnette TC, et al. Partial substitution of the functions of the herpes simplex virus 1 U(L)13 gene by the human cytomegalovirus U(L)97 gene. Virology 1996; 225: 347-358.
61. Merrick WC. Mechanism and regulation of eukaryotic protein synthesis. Microbiol Rev 1992; 56: 291-315.
62. Riis B, Rattan SI, Clark BF, et al. Eukaryotic protein elongation factors. Trends Biochem Sci 1990; 15: 420-424.
63. Morales J, Cormier P, Mulner-Lorillon O, et al. Molecular cloning of a new guanine nucleotide-exchange protein, EF1 delta. Nucleic Acids Res 1992; 20: 4091.
64. van Damme HT, Amons R, Karssies R, et al. Elongation factor 1 beta of artemia: localization of functional sites and homology to elongation factor 1 delta. Biochim Biophys Acta 1990; 1050: 241-247.
65. Kawaguchi Y, Bruni R, Roizman B. Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1 delta: ICP0 affects translational machinery. J Virol 1997; 71: 1019-1024.
66. Xiao H, Neuveut C, Benkirane M, et al. Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. Biochem Biophys Res Commun 1998; 244: 384-389.
67. Marin O, Meggio F, Draetta G, et al. The consensus sequences for cdc2 kinase and for casein kinase-2 are mutually incompatible. A study with peptides derived from the beta-subunit of casein kinase-2. FEBS Lett 1992; 301: 111-114.
68. Mulner-Lorillon O, Minella O, Cormier P, et al. Elongation factor EF-1 delta, a new target for maturation-promoting factor in Xenopus oocytes. J Biol Chem 1994; 269: 20201-20207.
69. Yokoyama A, Tanaka M, Matsuda G, et al. Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation. J Virol 2001; 75: 5119-5128.
70. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell 1994; 79: 563-571.
71. Smits VA, Medema RH. Checking out the G(2)/M transition. Biochim Biophys Acta 2001; 1519: 1-12.
72. Nigg EA. Targets of cyclin-dependent protein kinases. Curr Opin Cell Biol 1993; 5: 187-193.
73. Nigg EA. Cellular substrates of p34cdc2 and its companion cyclin-dependent kinases. Trends Cell Biol 1993; 3: 296-301.
74. Advani SJ, Weichselbaum RR, Roizman B. The role of cdc2 in the expression of herpes simplex virus genes. Proc Natl Acad Sci USA 2000; 97: 10996-11001.
75. Schang LM, Rosenberg A, Schaffer PA. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J Virol 1999; 73: 2161-2172.
76. Polson AG, Huang L, Lukac DM, et al. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J Virol 2001; 75: 3175-3184.
77. Kitay MK, Rowe DT. Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP. J Virol 1996; 70: 7885-7893.
78. Ye M, Duus KM, Peng J, et al. Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J Virol 1999; 73: 1320-1330.
79. Buendia B, Courvalin JC, Collas P. Dynamics of the nuclear envelope at mitosis and during apoptosis. Cell Mol Life Sci 2001; 58: 1781-1789.
80. Muranyi W, Haas J, Wagner M, et al. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 2002; 297: 854-857.
81. Overton H, McMillan D, Hope L, et al. Production of host shutoff-defective mutants of herpes simplex virus type 1 by inactivation of the UL13 gene. Virology 1994; 202: 97-106.